Abstract
After reading the chapter, the reader should be able to name the symptoms of schizophrenia as well as its treatment options and to classify different neurobiological explanations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adams RA, Stephan KE, Brown HR, Frith CD, Friston KJ (2013) The computational anatomy of psychosis. Front Psych 4:47. https://doi.org/10.3389/fpsyt.2013.00047
Aderhold V, Weinmann S, Hagele C, Heinz A (2015) Frontal brain volume reduction due to antipsychotic drugs? Nervenarzt 86(3):302–323. https://doi.org/10.1007/s00115-014-4027-5
Avramopoulos D (2018) Recent advances in the genetics of schizophrenia. Mol Neuropsychiatry 4(1):35–51. https://doi.org/10.1159/000488679
Bastos AM, Usrey WM, Adams RA, Mangun GR, Fries P, Friston KJ (2012) Canonical microcircuits for predictive coding. Neuron 76(4):695–711. https://doi.org/10.1016/j.neuron.2012.10.038
Berridge KC (2012) From prediction error to incentive salience: mesolimbic computation of reward motivation. Eur J Neurosci 35(7):1124–1143. https://doi.org/10.1111/j.1460-9568.2012.07990.x
Cechnicki A, Bielanska A, Hanuszkiewicz I, Daren A (2013) The predictive validity of expressed emotions (EE) in schizophrenia. A 20-year prospective study. J Psychiatr Res 47(2):208–214. https://doi.org/10.1016/j.jpsychires.2012.10.004
Corlett PR, Frith CD, Fletcher PC (2009) From drugs to deprivation: a Bayesian framework for understanding models of psychosis. Psychopharmacology 206(4):515–530. https://doi.org/10.1007/s00213-009-1561-0
Donnelly L, Rathbone J, Adams CE (2013) Haloperidol dose for the acute phase of schizophrenia. Cochrane Database Syst Rev 8:Cd001951. https://doi.org/10.1002/14651858.cd001951.pub2
Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49(7):538–544
Friston K (2005) A theory of cortical responses. Philos Trans R Soc Lond Ser B Biol Sci 360(1456):815–836. https://doi.org/10.1098/rstb.2005.1622
Friston KJ, Stephan KE, Montague R, Dolan RJ (2014) Computational psychiatry: the brain as a phantastic organ. Lancet Psychiatry 1(2):148–158. https://doi.org/10.1016/S2215-0366(14)70275-5
Frith CD, Done DJ (1989) Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action. Psychol Med 19(2):359–363
Gaebel WW (2010) Schizophrenie, vol 50. Robert Koch-Institut in Zusammenarbeit mit dem Statistischen Bundesamt, Berlin
Galea JM, Bestmann S, Beigi M, Jahanshahi M, Rothwell JC (2012) Action reprogramming in parkinson’s disease: response to prediction error is modulated by levels of dopamine. J Neurosci 32(2):542–550. https://doi.org/10.1523/jneurosci.3621-11.2012
Gao R, Penzes P (2015) Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med 15(2):146–167
Gonzalez-Burgos G, Cho RY, Lewis DA (2015) Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia. Biol Psychiatry 77(12):1031–1040. https://doi.org/10.1016/j.biopsych.2015.03.010
Green MF, Harvey PD (2014) Cognition in schizophrenia: past, present, and future. Schizophr Res Cogn 1(1):e1–e9. https://doi.org/10.1016/j.scog.2014.02.001
Häfner H (1995) Was ist Schizophrenie? In: Häfner H (ed) Was ist Schizophrenie? Fischer, Stuttgart, pp 1–56
Hecker (1871) Die Hebephrenie. Ein Beitrag zur klinischen Psychiatrie. Arch Pathol Anat Physiol Klin Med 52:394–429
Heckers S, Barch DM, Bustillo J, Gaebel W, Gur R, Malaspina D, Carpenter W (2013) Structure of the psychotic disorders classification in DSM-5. Schizophr Res 150(1):11–14. https://doi.org/10.1016/j.schres.2013.04.039
Heinz A (2002) Dopaminergic dysfunction in alcoholism and schizophrenia–psychopathological and behavioral correlates. Eur Psychiatry 17(1):9–16
Heinz A, Schlagenhauf F (2010) Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophr Bull 36(3):472–485. https://doi.org/10.1093/schbul/sbq031
Heinz A, Knable MB, Weinberger DR (1996) Dopamine D2 receptor imaging and neuroleptic drug response. J Clin Psychiatry 57(11):84–88; discussion 89–93
Heinz A, Deserno L, Reininghaus U (2013) Urbanicity, social adversity and psychosis. World Psychiatry 12(3):187–197. https://doi.org/10.1002/wps.20056
Heinz A, Murray GK, Schlagenhauf F, Sterzer P, Grace AA, Waltz JA (2018) Towards a unifying cognitive, neurophysiological, and computational neuroscience account of schizophrenia. Schizophr Bull. https://doi.org/10.1093/schbul/sby154
Helmholtz H (1867) Handbuch der physiologischen Optik. Voss, Leipzig
Hohwy J (2012) Attention and conscious perception in the hypothesis testing brain. Front Psychol 3:96. https://doi.org/10.3389/fpsyg.2012.00096
Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III–the final common pathway. Schizophr Bull 35(3):549–562. https://doi.org/10.1093/schbul/sbp006
Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S (2012) The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 69(8):776–786. https://doi.org/10.1001/archgenpsychiatry.2012.169
Kahlbaum K (1874) Die Katatonie oder das Spannungsirresein. Eine klinische Form psychischer Krankheit. A. Hirschwald, Berlin
Kahn RS, Keefe RS (2013) Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiat 70(10):1107–1112. https://doi.org/10.1001/jamapsychiatry.2013.155
Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, Insel TR (2015) Schizophrenia. Nat Rev Dis Primers 1:15067. https://doi.org/10.1038/nrdp.2015.67
Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160(1):13–23
Keshavan MS (1999) Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 33(6):513–521
Kirkbride J, Coid JW, Morgan C, Fearon P, Dazzan P, Yang M, Jones PB (2010) Translating the epidemiology of psychosis into public mental health: evidence, challenges and future prospects. J Public Ment Health 9(2):4–14. https://doi.org/10.5042/jpmh.2010.0324
Krystal JH, Anticevic A (2015) Toward illness phase-specific pharmacotherapy for schizophrenia. Biol Psychiatry 78(11):738–740. https://doi.org/10.1016/j.biopsych.2015.08.017
Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D’Souza CD, Erdos J, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci 93(17):9235–9240. https://doi.org/10.1073/pnas.93.17.9235
Lee TS, Mumford D (2003) Hierarchical Bayesian inference in the visual cortex. J Opt Soc Am A Opt Image Sci Vis 20(7):1434–1448
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209–1223. https://doi.org/10.1056/NEJMoa051688
Linscott RJ, van Os J (2013) An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med 43(6):1133–1149. https://doi.org/10.1017/s0033291712001626
Maia TV, Frank MJ (2017) An integrative perspective on the role of dopamine in schizophrenia. Biol Psychiatry 81(1):52–66. https://doi.org/10.1016/j.biopsych.2016.05.021
McGrath J, Saha S, Chant D, Welham J (2008) Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67–76. https://doi.org/10.1093/epirev/mxn001
Moller HJ (2004) Course and long-term treatment of schizophrenic psychoses. Pharmacopsychiatry 37(Suppl 2):126–135. https://doi.org/10.1055/s-2004-832666
National Collaborating Centre for Mental Health (2014) National Institute for Health and Clinical Excellence: guidance. In: Psychosis and schizophrenia in adults: treatment and management: updated edition 2014. National Institute for Health and Care Excellence (UK), London
Notredame CE, Pins D, Deneve S, Jardri R (2014) What visual illusions teach us about schizophrenia. Front Integr Neurosci 8:63. https://doi.org/10.3389/fnint.2014.00063
Rapoport JL, Giedd JN, Gogtay N (2012) Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 17(12):1228–1238. https://doi.org/10.1038/mp.2012.23
Ripke S, O’Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S, Sullivan PF (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45(10):1150–1159. https://doi.org/10.1038/ng.2742
Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18(3):247–291
Schneider U, Borsutzky M, Seifert J, Leweke FM, Huber TJ, Rollnik JD, Emrich HM (2002) Reduced binocular depth inversion in schizophrenic patients. Schizophr Res 53(1–2):101–108
Schultz W (2017) Reward prediction error. Curr Biol 27(10):R369–R371. https://doi.org/10.1016/j.cub.2017.02.064
Sterzer P, Adams RA, Fletcher P, Frith C, Lawrie SM, Muckli L, Corlett PR (2018) The predictive coding account of psychosis. Biol Psychiatry. https://doi.org/10.1016/j.biopsych.2018.05.015
Uhlhaas PJ, Singer W (2015) Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities. Biol Psychiatry 77(12):1001–1009. https://doi.org/10.1016/j.biopsych.2014.11.019
Valton V, Romaniuk L, Steele D, Lawrie S, Series P (2017) Comprehensive review: computational modelling of schizophrenia. Neurosci Biobehav Rev. https://doi.org/10.1016/j.neubiorev.2017.08.022
Watts CA (1985) A long-term follow-up of schizophrenic patients: 1946–1983. J Clin Psychiatry 46(6):210–216
Zipursky RB, Reilly TJ, Murray RM (2013) The myth of schizophrenia as a progressive brain disease. Schizophr Bull 39(6):1363–1372. https://doi.org/10.1093/schbul/sbs135
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer-Verlag GmbH, DE, part of Springer Nature
About this chapter
Cite this chapter
Schlagenhauf, F., Sterzer, P. (2023). Psychotic Disorders (“Schizophrenia”). In: Roth, G., Heinz, A., Walter, H. (eds) Psychoneuroscience. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-65774-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-65774-4_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-65773-7
Online ISBN: 978-3-662-65774-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)